216 related articles for article (PubMed ID: 21864238)
61. Gold complexes with the selenolate ligand [2-(Me2NCH2)C6H4Se]-.
Crespo O; Gimeno MC; Laguna A; Kulcsar M; Silvestru C
Inorg Chem; 2009 May; 48(9):4134-42. PubMed ID: 19326899
[TBL] [Abstract][Full Text] [Related]
62. Luminescent Cycloplatinated Complexes with Biologically Relevant Phosphine Ligands: Optical and Cytotoxic Properties.
Millán G; Giménez N; Lara R; Berenguer JR; Moreno MT; Lalinde E; Alfaro-Arnedo E; López IP; Piñeiro-Hermida S; Pichel JG
Inorg Chem; 2019 Jan; 58(2):1657-1673. PubMed ID: 30601653
[TBL] [Abstract][Full Text] [Related]
63. Characterization of Hydrophilic Gold(I) N-Heterocyclic Carbene (NHC) Complexes as Potent TrxR Inhibitors Using Biochemical and Mass Spectrometric Approaches.
Karaca Ö; Scalcon V; Meier-Menches SM; Bonsignore R; Brouwer JMJL; Tonolo F; Folda A; Rigobello MP; Kühn FE; Casini A
Inorg Chem; 2017 Nov; 56(22):14237-14250. PubMed ID: 29095609
[TBL] [Abstract][Full Text] [Related]
64. Gold(I) complex of 1,1'-bis(diphenylphosphino) ferrocene-quinoline conjugate: a virostatic agent against HIV-1.
Gama N; Kumar K; Ekengard E; Haukka M; Darkwa J; Nordlander E; Meyer D
Biometals; 2016 Jun; 29(3):389-97. PubMed ID: 26922346
[TBL] [Abstract][Full Text] [Related]
65. Selected cytotoxic gold compounds cause significant inhibition of 20S proteasome catalytic activities.
Micale N; Schirmeister T; Ettari R; Cinellu MA; Maiore L; Serratrice M; Gabbiani C; Massai L; Messori L
J Inorg Biochem; 2014 Dec; 141():79-82. PubMed ID: 25217719
[TBL] [Abstract][Full Text] [Related]
66. Structural and solution chemistry, protein binding and antiproliferative profiles of gold(I)/(III) complexes bearing the saccharinato ligand.
Maiore L; Cinellu MA; Michelucci E; Moneti G; Nobili S; Landini I; Mini E; Guerri A; Gabbiani C; Messori L
J Inorg Biochem; 2011 Mar; 105(3):348-55. PubMed ID: 21421122
[TBL] [Abstract][Full Text] [Related]
67. In vitro and in vivo antitumor properties of tetrakis((trishydroxy- methyl)phosphine)gold(I) chloride.
Pillarsetty N; Katti KK; Hoffman TJ; Volkert WA; Katti KV; Kamei H; Koide T
J Med Chem; 2003 Mar; 46(7):1130-2. PubMed ID: 12646023
[TBL] [Abstract][Full Text] [Related]
68. Cu
Bykowska A; Komarnicka UK; Jeżowska-Bojczuk M; Kyzioł A
J Inorg Biochem; 2018 Apr; 181():1-10. PubMed ID: 29348049
[TBL] [Abstract][Full Text] [Related]
69. Serum-Stable Gold(III) Bisphosphine Complex Induces Mild Mitochondrial Uncoupling and In Vivo Antitumor Potency in Triple Negative Breast Cancer.
Arojojoye AS; Olelewe C; Gukathasan S; Kim JH; Vekaria H; Parkin S; Sullivan PG; Awuah SG
J Med Chem; 2023 Jun; 66(12):7868-7879. PubMed ID: 37279147
[TBL] [Abstract][Full Text] [Related]
70. Iminophosphorane-organogold(III) complexes induce cell death through mitochondrial ROS production.
Vela L; Contel M; Palomera L; Azaceta G; Marzo I
J Inorg Biochem; 2011 Oct; 105(10):1306-13. PubMed ID: 21864808
[TBL] [Abstract][Full Text] [Related]
71. Gold(III) complexes with 2-substituted pyridines as experimental anticancer agents: solution behavior, reactions with model proteins, antiproliferative properties.
Maiore L; Cinellu MA; Nobili S; Landini I; Mini E; Gabbiani C; Messori L
J Inorg Biochem; 2012 Mar; 108():123-7. PubMed ID: 22173093
[TBL] [Abstract][Full Text] [Related]
72. Synthesis, cytotoxicity and anti-cancer activity of new alkynyl-gold(I) complexes.
De Nisi A; Bergamini C; Leonzio M; Sartor G; Fato R; Naldi M; Monari M; Calonghi N; Bandini M
Dalton Trans; 2016 Jan; 45(4):1546-53. PubMed ID: 26687209
[TBL] [Abstract][Full Text] [Related]
73. Synthesis, characterization, and in vitro studies of bis[1,3-diethyl-4,5-diarylimidazol-2-ylidene]gold(I/III) complexes.
Liu W; Bensdorf K; Proetto M; Hagenbach A; Abram U; Gust R
J Med Chem; 2012 Apr; 55(8):3713-24. PubMed ID: 22424185
[TBL] [Abstract][Full Text] [Related]
74. Gold-phosphine-porphyrin as potential metal-based theranostics.
Tasan S; Licona C; Doulain PE; Michelin C; Gros CP; Le Gendre P; Harvey PD; Paul C; Gaiddon C; Bodio E
J Biol Inorg Chem; 2015 Jan; 20(1):143-154. PubMed ID: 25476859
[TBL] [Abstract][Full Text] [Related]
75. Exploring the C^N^C theme: Synthesis and biological properties of tridentate cyclometalated gold(III) complexes.
Jürgens S; Scalcon V; Estrada-Ortiz N; Folda A; Tonolo F; Jandl C; Browne DL; Rigobello MP; Kühn FE; Casini A
Bioorg Med Chem; 2017 Oct; 25(20):5452-5460. PubMed ID: 28823538
[TBL] [Abstract][Full Text] [Related]
76. Inhibition of lipoxygenase (LOX) and anticancer activity caused by gold(I) mixed ligands complexes of triphenylphosphine and thioamides.
Georgiou E; Metsios A; Kourkoumelis N; Karkabounas S; Charalabopoulos K; Badeka A; Hadjikakou SK
J Enzyme Inhib Med Chem; 2011 Aug; 26(4):592-7. PubMed ID: 21087193
[TBL] [Abstract][Full Text] [Related]
77. Organogold(III) compounds as experimental anticancer agents: chemical and biological profiles.
Massai L; Cirri D; Michelucci E; Bartoli G; Guerri A; Cinellu MA; Cocco F; Gabbiani C; Messori L
Biometals; 2016 Oct; 29(5):863-72. PubMed ID: 27476157
[TBL] [Abstract][Full Text] [Related]
78. Cytotoxicity of ferrocenyl-ethynyl phosphine metal complexes of gold and platinum.
Fourie E; Erasmus E; Swarts JC; Jakob A; Lang H; Joone GK; VAN Rensburg CE
Anticancer Res; 2011 Mar; 31(3):825-9. PubMed ID: 21498702
[TBL] [Abstract][Full Text] [Related]
79. Anticancer therapeutics that target selenoenzymes: synthesis, characterization, in vitro cytotoxicity, and thioredoxin reductase inhibition of a series of gold(I) complexes containing hydrophilic phosphine ligands.
Vergara E; Casini A; Sorrentino F; Zava O; Cerrada E; Rigobello MP; Bindoli A; Laguna M; Dyson PJ
ChemMedChem; 2010 Jan; 5(1):96-102. PubMed ID: 19937669
[TBL] [Abstract][Full Text] [Related]
80. Atypical fluoroquinolone gold(III) chelates as potential anticancer agents: relevance of DNA and protein interactions for their mechanism of action.
Gouvea LR; Garcia LS; Lachter DR; Nunes PR; de Castro Pereira F; Silveira-Lacerda EP; Louro SR; Barbeira PJ; Teixeira LR
Eur J Med Chem; 2012 Sep; 55():67-73. PubMed ID: 22835721
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
